@cbretzmullaney.bsky.social
Reposted
We’re proud to congratulate our clients named to the U.S. News & World Report 2025–2026 Best Hospitals list! These rankings reflect a hospital’s dedication to exceptional patient care, innovation, and outcomes. Congrats to all who achieved this well-deserved recognition!
#BestHospitals
#BestHospitals
August 28, 2025 at 8:21 PM
We’re proud to congratulate our clients named to the U.S. News & World Report 2025–2026 Best Hospitals list! These rankings reflect a hospital’s dedication to exceptional patient care, innovation, and outcomes. Congrats to all who achieved this well-deserved recognition!
#BestHospitals
#BestHospitals
Reposted
#Menopause transition (MT) raises sx & cardiometabolic Ds, increasing women's CVD risk but also offers a chance for early prevention. Check @jaccjournals.bsky.social for multidisciplinary guidance to lower MT CV risk! www.jacc.org/doi/10.1016/... #CardioSky #MedSky
Improving Cardiovascular Clinical Competencies for the Menopausal Transition: A Focus on Cardiometabolic Health in Midlife
www.jacc.org
July 7, 2025 at 4:57 PM
#Menopause transition (MT) raises sx & cardiometabolic Ds, increasing women's CVD risk but also offers a chance for early prevention. Check @jaccjournals.bsky.social for multidisciplinary guidance to lower MT CV risk! www.jacc.org/doi/10.1016/... #CardioSky #MedSky
Reposted
1/43 Welcome to this #CME #Skeetorial on transthyretin amyloid cardiomyopathy (ATTR-CM), including updates in treatment from ACC25, with cardiologist @mkittlesonmd.bsky.social.
Earn credit: link.med-iq.com/6h6qnR
#Cardiology #CardioEd #MedEd
Earn credit: link.med-iq.com/6h6qnR
#Cardiology #CardioEd #MedEd
June 30, 2025 at 5:49 PM
1/43 Welcome to this #CME #Skeetorial on transthyretin amyloid cardiomyopathy (ATTR-CM), including updates in treatment from ACC25, with cardiologist @mkittlesonmd.bsky.social.
Earn credit: link.med-iq.com/6h6qnR
#Cardiology #CardioEd #MedEd
Earn credit: link.med-iq.com/6h6qnR
#Cardiology #CardioEd #MedEd
Reposted
Sports physical time! Timely article on professional liability risks w/SCA screening, return2play decisions, and counseling ↑risk athletes on participation choices & adequate rescue plans for potential CV events. www.sciencedirect.com/science/arti...
#CardioSky #MedSky
#CardioSky #MedSky
July 1, 2025 at 7:10 PM
Sports physical time! Timely article on professional liability risks w/SCA screening, return2play decisions, and counseling ↑risk athletes on participation choices & adequate rescue plans for potential CV events. www.sciencedirect.com/science/arti...
#CardioSky #MedSky
#CardioSky #MedSky
Reposted
Patients w/ #HCM may be asymptomatic or may have nonspecific symptoms that are identified incidentally and overlap with other diseases. Thus, HCM is regarded as “the great masquerader”. Patients may adapt their lifestyles to accommodate limitations as their symptoms progress. #CardioSky #MedSky
February 14, 2025 at 4:02 PM
Patients w/ #HCM may be asymptomatic or may have nonspecific symptoms that are identified incidentally and overlap with other diseases. Thus, HCM is regarded as “the great masquerader”. Patients may adapt their lifestyles to accommodate limitations as their symptoms progress. #CardioSky #MedSky
Reposted
1/12 Meet this patient with end-stage heart failure #eshf and test your knowledge in this #skeetorial.
#CardioSky #MedSky #FOAMed #MedEd
#CardioSky #MedSky #FOAMed #MedEd
February 11, 2025 at 8:05 PM
1/12 Meet this patient with end-stage heart failure #eshf and test your knowledge in this #skeetorial.
#CardioSky #MedSky #FOAMed #MedEd
#CardioSky #MedSky #FOAMed #MedEd
Reposted
Did you know that a 2023 cohort study of 1,660 people with #HCM found vigorous exercise (vs moderate or a sedentary lifestyle) was NOT associated with higher mortality or a higher number of life-threatening #arrhythmias? #CardioSky #MedSky
February 10, 2025 at 3:40 PM
Did you know that a 2023 cohort study of 1,660 people with #HCM found vigorous exercise (vs moderate or a sedentary lifestyle) was NOT associated with higher mortality or a higher number of life-threatening #arrhythmias? #CardioSky #MedSky
Reposted
Reposted
Wednesday, 8 pm ET: Feeling Breathless or Stressed? Is It Normal or Is It #HCM? Learn how to identify the signs and symptoms of #hypertrophiccardiomyopathy, communicate with clinicians, and ultimately receive a timely and accurate diagnosis. #PatientEducation www.facebook.com/educateddebu...
February 10, 2025 at 4:09 PM
Wednesday, 8 pm ET: Feeling Breathless or Stressed? Is It Normal or Is It #HCM? Learn how to identify the signs and symptoms of #hypertrophiccardiomyopathy, communicate with clinicians, and ultimately receive a timely and accurate diagnosis. #PatientEducation www.facebook.com/educateddebu...
Reposted
18/The phase 3 SEQUOIA-HCM trial found that an investigational CMI—aficamten—for 24 weeks resulted in significantly greater improvement in pVO2 than placebo (least-squares mean between-group difference, 1.7 mL/kg/min; 95% CI, 1.0 to 2.4; P < .001).
January 7, 2025 at 6:46 PM
18/The phase 3 SEQUOIA-HCM trial found that an investigational CMI—aficamten—for 24 weeks resulted in significantly greater improvement in pVO2 than placebo (least-squares mean between-group difference, 1.7 mL/kg/min; 95% CI, 1.0 to 2.4; P < .001).
Reposted
Final AZALEA-TIMI 71 results confirm #AHA23 buzz: abelacimab ↓major/clinically relevant nonmajor bleeding compared w/rivaroxaban in patients w/AF and mod-to-high stroke risk. However, we must wait for Ph3 data to understand effects on stroke prevention. #Medsky #Cardiosky #Cardiology
In patients with atrial fibrillation and moderate-to-high risk of stroke, abelacimab, a monoclonal antibody that inhibits activation of factor XI, led to fewer bleeding events than rivaroxaban. Read the full AZALEA–TIMI 71 trial results: nej.md/3PJcknN
#MedSky #Cardiology
#MedSky #Cardiology
February 5, 2025 at 6:05 PM
Final AZALEA-TIMI 71 results confirm #AHA23 buzz: abelacimab ↓major/clinically relevant nonmajor bleeding compared w/rivaroxaban in patients w/AF and mod-to-high stroke risk. However, we must wait for Ph3 data to understand effects on stroke prevention. #Medsky #Cardiosky #Cardiology
Reposted
Are You Red-y? This Friday, Feb. 7, 2025, is National Wear Red Day. Wear Red and Save Lives! Join me as I wear red and help raise awareness of women’s No. 1 killer – cardiovascular disease. @ahascience.bsky.social @americanheart.bsky.social @stanfordcvi.bsky.social
February 6, 2025 at 2:05 AM
Are You Red-y? This Friday, Feb. 7, 2025, is National Wear Red Day. Wear Red and Save Lives! Join me as I wear red and help raise awareness of women’s No. 1 killer – cardiovascular disease. @ahascience.bsky.social @americanheart.bsky.social @stanfordcvi.bsky.social
Reposted
One of the most impactful changes to the 2024 update to the @americanheart.bsky.social / @accintouch.bsky.social #HCM Guideline is the addition of myosin inhibitors in the second-line treatment of adults with symptomatic oHCM. #CardioSky #MedSky #MedEd #Cardiology
February 3, 2025 at 3:49 PM
One of the most impactful changes to the 2024 update to the @americanheart.bsky.social / @accintouch.bsky.social #HCM Guideline is the addition of myosin inhibitors in the second-line treatment of adults with symptomatic oHCM. #CardioSky #MedSky #MedEd #Cardiology
Reposted
A big change in the @accintouch.bsky.social @ahascience.bsky.social #HCM guideline involves exercise, which was historically discouraged for patients with HCM because of a perceived higher risk of arrhythmias or SCD. #CardioSky #MedSky #MedEd
January 30, 2025 at 2:33 PM
A big change in the @accintouch.bsky.social @ahascience.bsky.social #HCM guideline involves exercise, which was historically discouraged for patients with HCM because of a perceived higher risk of arrhythmias or SCD. #CardioSky #MedSky #MedEd
Reposted
Learn how to leverage the latest clinical data and expert recommendations in this episode of @accintouch.bsky.social Podcast, CardiaCast.
#HCM #CardioSky #MedSky
open.spotify.com/episode/4WXO...
#HCM #CardioSky #MedSky
open.spotify.com/episode/4WXO...
2024 Update to the AHA/ACC HCM Guideline: Focus on Early Diagnosis and New and Emerging Treatments
ACC CardiaCast · Episode
open.spotify.com
January 30, 2025 at 2:47 PM
Learn how to leverage the latest clinical data and expert recommendations in this episode of @accintouch.bsky.social Podcast, CardiaCast.
#HCM #CardioSky #MedSky
open.spotify.com/episode/4WXO...
#HCM #CardioSky #MedSky
open.spotify.com/episode/4WXO...
Reposted
Celebrating #CEProfessionalsDay alongside all the amazing continuing education professionals. Thanks to the dedicated Med-IQ team and all their efforts to achieve our vision of #BetterHealthcareForAll
January 24, 2025 at 4:16 PM
Celebrating #CEProfessionalsDay alongside all the amazing continuing education professionals. Thanks to the dedicated Med-IQ team and all their efforts to achieve our vision of #BetterHealthcareForAll
Reposted
19/Thank you for joining this #CME activity!
To earn CME credit or view references: clinical.med-iq.com/activity/1889
Interested in more on this topic? View the ACC CardiaCast: www.acc.org/Latest-in-Ca...
To earn CME credit or view references: clinical.med-iq.com/activity/1889
Interested in more on this topic? View the ACC CardiaCast: www.acc.org/Latest-in-Ca...
January 7, 2025 at 6:46 PM
19/Thank you for joining this #CME activity!
To earn CME credit or view references: clinical.med-iq.com/activity/1889
Interested in more on this topic? View the ACC CardiaCast: www.acc.org/Latest-in-Ca...
To earn CME credit or view references: clinical.med-iq.com/activity/1889
Interested in more on this topic? View the ACC CardiaCast: www.acc.org/Latest-in-Ca...
Reposted
1/19 Welcome to this #CME activity with Matthew Martinez, MD, FACC, coauthor of the updated #HCM guideline. Provided by @accintouch.bsky.social and Med-IQ and supported by an educational grant from Bristol Myers Squibb. #MedEd
Participate for credit: clinical.med-iq.com/activity/1889
Participate for credit: clinical.med-iq.com/activity/1889
January 7, 2025 at 6:46 PM
1/19 Welcome to this #CME activity with Matthew Martinez, MD, FACC, coauthor of the updated #HCM guideline. Provided by @accintouch.bsky.social and Med-IQ and supported by an educational grant from Bristol Myers Squibb. #MedEd
Participate for credit: clinical.med-iq.com/activity/1889
Participate for credit: clinical.med-iq.com/activity/1889
Reposted
1/19 Welcome to this #CME activity with Matthew Martinez, MD, FACC, coauthor of the updated #HCM guideline. Provided by @accintouch.bsky.social and Med-IQ and supported by an educational grant from Bristol Myers Squibb. #MedEd
Participate for credit: clinical.med-iq.com/activity/1889
Participate for credit: clinical.med-iq.com/activity/1889
January 9, 2025 at 4:02 PM
Reposted
In this case-based activity, meet a patient who presents with diarrhea, intermittent hematochezia, and pain. Move through the activity to choose appropriate treatment that safely induces remission and optimizes quality of life for patients. clinical.med-iq.com/activity/dec...
January 7, 2025 at 9:54 PM
In this case-based activity, meet a patient who presents with diarrhea, intermittent hematochezia, and pain. Move through the activity to choose appropriate treatment that safely induces remission and optimizes quality of life for patients. clinical.med-iq.com/activity/dec...
Reposted
Listen to this @accintouch.bsky.social CardiaCast featuring Matthew Martinez, MD, FACC, as he reviews changes occurring in the field of #HCM and explores best practice recommendations from the recently issued guideline.
open.spotify.com/episode/6aN7...
open.spotify.com/episode/6aN7...
January 7, 2025 at 9:49 PM
Listen to this @accintouch.bsky.social CardiaCast featuring Matthew Martinez, MD, FACC, as he reviews changes occurring in the field of #HCM and explores best practice recommendations from the recently issued guideline.
open.spotify.com/episode/6aN7...
open.spotify.com/episode/6aN7...
Reposted
Fewer than 10% of eligible patients undergo lung cancer screening. Explore screening guidelines and the use of shared decision making with eligible patients in this accredited webcast. clinical.med-iq.com/activity/1868 #lungcancer #lungcancerscreening #pulmonology
January 7, 2025 at 9:57 PM
Fewer than 10% of eligible patients undergo lung cancer screening. Explore screening guidelines and the use of shared decision making with eligible patients in this accredited webcast. clinical.med-iq.com/activity/1868 #lungcancer #lungcancerscreening #pulmonology
Reposted
This brief patient case scenario allows busy clinicians to quickly apply their knowledge on strategies for managing end-stage heart failure, with a focus on treatment modalities and clinical decision-making processes. @dukehealth.bsky.social
clinical.med-iq.com/activity/1861
clinical.med-iq.com/activity/1861
January 7, 2025 at 10:11 PM
This brief patient case scenario allows busy clinicians to quickly apply their knowledge on strategies for managing end-stage heart failure, with a focus on treatment modalities and clinical decision-making processes. @dukehealth.bsky.social
clinical.med-iq.com/activity/1861
clinical.med-iq.com/activity/1861